Immunization Services Model for Adult Rate Improvement

Immunization Clinical Trial

— ImmuSMART  

Official title:

Immunization Services Model for Adult Rate Improvement

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02609035
• Other study ID #: Pro00014163
• Status: Completed
• Phase: N/A
• First received: November 17, 2015
• Last updated: April 25, 2017
• Start date: March 31, 2016
• Est. completion date: March 31, 2017

Study information

• Verified date: April 2017
• Source: Pharmacy Quality Alliance
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

ImmuSMART is a study of personalized telephonic prompts to community pharmacy patients to improve adult vaccination rates for pneumococcal and herpes zoster vaccines.

Description:

This study will investigate immunization rate improvement among adult patients in 250 northeastern US community pharmacies as a result of telephonic prompts during regular automated outbound communiqués. There will be three projects assessing different forms of these appended prompts—appointment-based medication synchronization automated prompts, refill ready automated prompts, and refill reminder automated prompts. Each intervention will occur in one of three pharmacy chains, each with approximately 10,000 patients randomized to control or intervention (receive prompt or no).

Prior to the outbound automated call to the patient, a third-party technology vendor (Scientific Technologies Corporation) will perform an automated immunization status assessment of the patient by submitting a query the state immunization registry to compare the adult patient's existing immunization record to the CDC Recommended Adult Immunization Schedule. Gaps in immunizations that fall within pharmacy scope of practice will be identified. During the automated call (performed by VoicePort, a pharmacy telephonic support vendor) to the patient, they will be prompted to receive identified immunization gap vaccines upon their next pharmacy visit, with priority on pneumococcal, influenza, and herpes zoster vaccinations. If the patient accepts, the vaccination will be delivered when next the patient comes to visit the pharmacy.

After 6 months of running the trial, statistical modeling will be employed to assess vaccination rate differences between control and intervention patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 22301
• Est. completion date: March 31, 2017
• Est. primary completion date: March 31, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• Patient at least 19 years of age at date of enrollment

• Patient not in long-term care, hospice or otherwise identified as unable to come to pharmacy for receipt of vaccine

• Patient currently missing a record of receipt of at least one of three vaccinations:

flu, pneumonia, or shingles

• Patient enrolled in telephonic pharmacy reminder service

Related Conditions & MeSH terms

• Immunization
• Pharmacy
• Vaccines

Intervention

Behavioral:
• Telephonic prompt

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Pharmacy Quality Alliance

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Vaccination rates	Administration of vaccine will be assessed at 3 months after patient receives the prompt	3 months